Follow the latest coverage, related explainers and connected technology stories.
The Centers for Medicare and Medicaid Services approved coverage for transcatheter aortic valve replacement for patients with severe aortic stenosis even without symptoms. Analysts expect Edwards Lifesciences to benefit particularly, while evidence continues to be collected on this patient group.